Clinical features of spinal and bulbar muscular atrophy-Reference-Cited by-同舟云学术

Clinical features of spinal and bulbar muscular atrophy

Published:2009-10-21 Issue:12 Volume:132 Page:3242-3251
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Rhodes Lindsay E.,Freeman Brandi K.,Auh Sungyoung,Kokkinis Angela D.,La Pean Alison,Chen Cheunju,Lehky Tanya J.,Shrader Joseph A.,Levy Ellen W.,Harris-Love Michael,Di Prospero Nicholas A.,Fischbeck Kenneth H.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/132/12/3242/13734602/awp258.pdf

Reference38 articles.

1. A comparison of three measures of disease progression in ALS;Andres;J Neurol Sci,1996

2. Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease);Antonini;Muscle Nerve,2000

3. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients;Atsuta;Brain,2006

4. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy;Banno;Ann Neurol,2009

5. The feasibility of six-minute and two-minute walk tests in in-patient geriatric rehabilitation;Brooks;Can J Aging,2007

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introductory Chapter: Motor Neurons – New Insights;Motor Neurons - New Insights;2024-06-19

2. The Role of NRF2 in Trinucleotide Repeat Expansion Disorders;Antioxidants;2024-05-26

3. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands;Neuromuscular Disorders;2024-05

4. Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade;International Journal of Molecular Sciences;2024-04-28

5. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects;PROTEOMICS;2024-04-14